{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:19:11Z","timestamp":1789496351766,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"US National Institute of Neurological Disorders and Stroke","doi-asserted-by":"crossref","award":["NS 47920"],"award-info":[{"award-number":["NS 47920"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.pbb.2011.06.026","type":"journal-article","created":{"date-parts":[[2011,7,9]],"date-time":"2011-07-09T00:24:13Z","timestamp":1310171053000},"page":"704-711","source":"Crossref","is-referenced-by-count":76,"title":["Melatonin protects against neurobehavioral and mitochondrial deficits in a chronic mouse model of Parkinson's disease"],"prefix":"10.1016","volume":"99","author":[{"given":"Gaurav","family":"Patki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuen-Sum","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2011.06.026_bb0005","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1034\/j.1600-079X.2001.300201.x","article-title":"Melatonin, mitochondria, and cellular bioenergetics","volume":"30","author":"Acuna-Castroviejo","year":"2001","journal-title":"J Pineal Res"},{"key":"10.1016\/j.pbb.2011.06.026_bb0010","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1089\/rej.2009.0854","article-title":"Neuroprotective effect of long-term NDI1 gene expression in a chronic mouse model of Parkinson disorder","volume":"12","author":"Barber-Singh","year":"2009","journal-title":"Rejuvenation Res"},{"key":"10.1016\/j.pbb.2011.06.026_bb0015","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/ng1769","article-title":"High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease","volume":"38","author":"Bender","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.pbb.2011.06.026_bb0020","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson's disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pbb.2011.06.026_bb0025","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0301-0082(01)00003-X","article-title":"Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease","volume":"65","author":"Blum","year":"2001","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pbb.2011.06.026_bb0030","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1177\/074873049701200611","article-title":"Acute and delayed effects of exercise on human melatonin secretion","volume":"12","author":"Buxton","year":"1997","journal-title":"J Biol Rhythms"},{"key":"10.1016\/j.pbb.2011.06.026_bb0035","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejphar.2008.07.022","article-title":"Melatonin attenuates tyrosine hydroxylase loss and hypolocomotion in MPTP-lesioned rats","volume":"594","author":"Capitelli","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2011.06.026_bb0040","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1196\/annals.1427.027","article-title":"Mitochondrial approaches for neuroprotection","volume":"1147","author":"Chaturvedi","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pbb.2011.06.026_bb0045","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1097\/MCO.0b013e3282f0dbfb","article-title":"Mitochondrial dysfunction and age","volume":"10","author":"Conley","year":"2007","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.pbb.2011.06.026_bb0050","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0165-0270(91)90081-A","article-title":"A new motor test sensitive to aging and dopaminergic function","volume":"39","author":"Drucker-Colin","year":"1991","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.pbb.2011.06.026_bb0055","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1073\/pnas.0605208103","article-title":"Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons","volume":"104","author":"Ekstrand","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pbb.2011.06.026_bb0060","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1073\/pnas.0409713102","article-title":"Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin\u2013proteasome system and alpha-synuclein","volume":"102","author":"Fornai","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pbb.2011.06.026_bb0065","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/S0891-5849(02)00804-3","article-title":"The relationship between oxidative\/nitrative stress and pathological inclusions in Alzheimer's and Parkinson's diseases","volume":"32","author":"Giasson","year":"2002","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pbb.2011.06.026_bb0070","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/ana.410370604","article-title":"Low platelet mitochondrial complex I and complex II\/III activity in early untreated Parkinson's disease","volume":"37","author":"Haas","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pbb.2011.06.026_bb0075","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000048238","article-title":"Circadian rhythms of dopamine and dihydroxyphenyl acetic acid in the mouse striatum: effects of pinealectomy and of melatonin treatment","volume":"75","author":"Khaldy","year":"2002","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.pbb.2011.06.026_bb0080","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1006\/exnr.1998.6993","article-title":"The inflammatory reaction following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxication in mouse","volume":"156","author":"Kurkowska-Jastrzebska","year":"1999","journal-title":"Exp Neurol"},{"key":"10.1016\/j.pbb.2011.06.026_bb0085","series-title":"Parkinson's disease","first-page":"109","article-title":"Progressive neurodegeneration in the MPTP\/probenecid model of Parkinson's disease","author":"Lau","year":"2005"},{"key":"10.1016\/j.pbb.2011.06.026_bb0090","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0306-3623(90)90898-V","article-title":"Effects of probenecid on striatal dopamine depletion in acute and long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice","volume":"21","author":"Lau","year":"1990","journal-title":"Gen Pharmacol"},{"key":"10.1016\/j.pbb.2011.06.026_bb0095","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.neures.2005.04.010","article-title":"MPTP treatment in mice does not transmit and cause Parkinsonian neurotoxicity in non-treated cagemates through close contact","volume":"52","author":"Lau","year":"2005","journal-title":"Neurosci Res"},{"key":"10.1016\/j.pbb.2011.06.026_bb0100","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1111\/j.1460-9568.2011.07626.x","article-title":"Neuroprotective effects and mechanisms of exercise in a chronic mouse model of Parkinson's disease with moderate neurodegeneration","volume":"33","author":"Lau","year":"2011","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pbb.2011.06.026_bb0105","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1515\/REVEH.2002.17.1.51","article-title":"Age\u2013environment and gene\u2013environment interactions in the pathogenesis of Parkinson's disease","volume":"17","author":"Le Couteur","year":"2002","journal-title":"Rev Environ Health"},{"key":"10.1016\/j.pbb.2011.06.026_bb0110","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF00498052","article-title":"Diurnal rhythm in the central dopamine turnover in the rat","volume":"303","author":"Lemmer","year":"1978","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.pbb.2011.06.026_bb0115","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1600-079X.2007.00510.x","article-title":"Melatonin reduces the neuronal loss, downregulation of dopamine transporter, and upregulation of D2 receptor in rotenone-induced parkinsonian rats","volume":"44","author":"Lin","year":"2008","journal-title":"J Pineal Res"},{"key":"10.1016\/j.pbb.2011.06.026_bb0120","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.parkreldis.2008.07.008","article-title":"Does melatonin help save dopaminergic cells in MPTP-treated mice?","volume":"15","author":"Ma","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.pbb.2011.06.026_bb0125","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0006-8993(02)03514-X","article-title":"Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson's disease","volume":"956","author":"Meredith","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2011.06.026_bb0130","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0006-8993(01)03106-7","article-title":"Chronic administration of pharmacological levels of melatonin does not ameliorate the MPTP-induced degeneration of the nigrostriatal pathway","volume":"921","author":"Morgan","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2011.06.026_bb0135","doi-asserted-by":"crossref","first-page":"9584","DOI":"10.1073\/pnas.1631069100","article-title":"Bimodal circadian secretion of melatonin from the pineal gland in a living CBA mouse","volume":"100","author":"Nakahara","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pbb.2011.06.026_bb0140","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neuroscience.2006.02.007","article-title":"Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine\/probenecid model of Parkinson's disease","volume":"140","author":"Novikova","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2011.06.026_bb0145","doi-asserted-by":"crossref","first-page":"18614","DOI":"10.1074\/jbc.M401135200","article-title":"Mitochondrial dysfunction and oxidative damage in parkin-deficient mice","volume":"279","author":"Palacino","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pbb.2011.06.026_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/neuro.24.003.2009","article-title":"Mitochondrial dysfunction in the striatum of aged chronic mouse model of Parkinson's disease","volume":"1","author":"Patki","year":"2009","journal-title":"Front Aging neurosci"},{"key":"10.1016\/j.pbb.2011.06.026_bb0155","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0306-4522(01)00295-0","article-title":"Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP\/probenecid treatment","volume":"106","author":"Petroske","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2011.06.026_bb0160","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2202-10-6","article-title":"Restorative effect of endurance exercise on behavioral deficits in the chronic mouse model of Parkinson's disease with severe neurodegeneration","volume":"10","author":"Pothakos","year":"2009","journal-title":"BMC Neurosci"},{"key":"10.1016\/j.pbb.2011.06.026_bb0165","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0006-8993(87)90120-X","article-title":"Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra","volume":"403","author":"Ricaurte","year":"1987","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2011.06.026_bb0170","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1600-079X.1986.tb00760.x","article-title":"Human melatonin production decreases with age","volume":"3","author":"Sack","year":"1986","journal-title":"J Pineal Res"},{"key":"10.1016\/j.pbb.2011.06.026_bb0175","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1600-079X.2006.00412.x","article-title":"Melatonin protects against rotenone-induced oxidative stress in a hemiparkinsonian rat model","volume":"42","author":"Saravanan","year":"2007","journal-title":"J Pineal Res"},{"key":"10.1016\/j.pbb.2011.06.026_bb0180","series-title":"Pharmacology of cerebral ischemia","first-page":"201","article-title":"Disentangling multiple types of recovery from brain injury","author":"Schallert","year":"2002"},{"key":"10.1016\/j.pbb.2011.06.026_bb0185","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","article-title":"Mitochondrial complex I deficiency in Parkinson's disease","volume":"54","author":"Schapira","year":"1990","journal-title":"J Neurochem"},{"key":"10.1016\/j.pbb.2011.06.026_bb0190","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.brainres.2005.10.084","article-title":"Physiological neuroprotection by melatonin in a 6-hydroxydopamine model of Parkinson's disease","volume":"1068","author":"Sharma","year":"2006","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2011.06.026_bb0195","doi-asserted-by":"crossref","first-page":"152","DOI":"10.2174\/1874609810801030152","article-title":"Melatonin causes gene expression in aged animals to respond to inflammatory stimuli in a manner differing from that of young animals","volume":"1","author":"Sharman","year":"2008","journal-title":"Curr Aging Sci"},{"key":"10.1016\/j.pbb.2011.06.026_bb0200","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0014-4886(03)00342-X","article-title":"Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP","volume":"186","author":"Song","year":"2004","journal-title":"Exp Neurol"},{"key":"10.1016\/j.pbb.2011.06.026_bb0205","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2174\/1568026023394443","article-title":"Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger","volume":"2","author":"Tan","year":"2002","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.pbb.2011.06.026_bb0210","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/jnr.22201","article-title":"Melatonin treatment potentiates neurodegeneration in a rat rotenone Parkinson's disease model","volume":"88","author":"Tapias","year":"2010","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.pbb.2011.06.026_bb0215","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/1531-8249(200011)48:5<730::AID-ANA6>3.0.CO;2-0","article-title":"A novel mitochondrial 12SrRNA point mutation in parkinsonism, deafness, and neuropathy","volume":"48","author":"Thyagarajan","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pbb.2011.06.026_bb0220","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1054\/ceca.2000.0167","article-title":"Age-related structural and functional changes of brain mitochondria","volume":"28","author":"Toescu","year":"2000","journal-title":"Cell Calcium"},{"key":"10.1016\/j.pbb.2011.06.026_bb0225","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/BF03033256","article-title":"Melatonin fails to protect against long-term MPTP-induced dopamine depletion in mouse striatum","volume":"1","author":"van der Schyf","year":"2000","journal-title":"Neurotox Res"},{"key":"10.1016\/j.pbb.2011.06.026_bb0230","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/nm0602-600","article-title":"Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease","volume":"8","author":"Xu","year":"2002","journal-title":"Nat Med"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305711002309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305711002309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T21:54:01Z","timestamp":1686174841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305711002309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0091305711002309"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2011.06.026","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}